Attributes | Values |
---|
rdf:type
| |
description
| - videnskabelig artikel (da)
- article científic (ca)
- articol științific (ro)
- articolo scientifico (it)
- artigo científico (gl)
- artigo científico (pt)
- artigo científico (pt-br)
- artikull shkencor (sq)
- artículo científico (es)
- bilimsel makale (tr)
- scienca artikolo (eo)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vitenskapelig artikkel (nb)
- vitskapeleg artikkel (nn)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- научная статья (ru)
- научни чланак (sr)
- מאמר מדעי (he)
- artikel ilmiah (id)
- article scientifique (fr)
- বৈজ্ঞানিক নিবন্ধ (bn)
- artículu científicu espublizáu en 2006 (ast)
- 2006 nî lūn-bûn (nan)
- 2006年の論文 (ja)
- 2006年論文 (zh-hk)
- 2006年論文 (zh-tw)
- 2006年論文 (zh-hant)
- 2006年論文 (yue)
- 2006年論文 (zh-mo)
- 2006年论文 (zh)
- 2006年论文 (zh-cn)
- 2006年论文 (zh-sg)
- 2006年论文 (zh-hans)
- 2006年论文 (wuu)
- 2006年论文 (zh-my)
- 2006년 논문 (ko)
- наукова стаття, опублікована у вересні 2006 (uk)
- scientific article published on 12 September 2006 (en-ca)
- scientific article published on 12 September 2006 (en-gb)
- مقالة علمية نشرت في 12 سبتمبر 2006 (ar)
- scientific article published on 12 September 2006 (en)
- 2006 թվականի սեպտեմբերի 12-ին հրատարակված գիտական հոդված (hy)
|
publication date
| |
publication date
| |
language of work or name
| |
language of work or name
| |
author name string
| |
author name string
| - Antonio Hernandez-Ono
- Henry N Ginsberg
- Mark J Graham
- Rosanne M Crooke
- Yuan-Li Zhang
- Li-Shin Huang
- Donna Conlon
- Patty Siri
|
rdfs:label
| - Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. (en)
- Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. (nl)
- Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. (ast)
|
skos:prefLabel
| - Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. (en)
- Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. (nl)
- Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. (ast)
|
name
| - Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. (en)
- Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. (nl)
- Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. (ast)
|
author
| |
author
| |
title
| |
title
| - Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |